Table 1 Baseline characteristics (n = 17)
Baseline characteristics | n (% or range) |
|---|---|
Age | 66 (45–79) |
Baseline PSA (ng/mL) | 79.7 (3.9–2356) |
Baseline Hemoglobin (g/dL) | 12.2 (9.3–14.5) |
Baseline LDH (U/L) | 241 (153–351) |
Baseline Alkaline Phosphatase (U/L) | 80 (56–643) |
Baseline CTCs (in 10 mL blood) | 12 (0–2107) |
Prior treatment with: | |
 Enzalutamide | 16 (94%) |
 Abiraterone | 11 (65%) |
 Both | 10 (59%) |
 Prior immunotherapy | 8 (47%) |
 Prior chemotherapy | 11 (65%) |
Gleason score | |
 <  8 | 5 (29%) |
 8–10 | 12 (71%) |
ECOG performance status | |
 0 | 2 (12%) |
 1 | 14 (82%) |
 2 | 1 (6%) |
Disease site: | |
 Bone only | 5 (29%) |
 Bone/soft tissue/viscera | 12 (71%) |